Last reviewed · How we verify
Standard pain management regimen
This drug works by targeting the opioid receptors in the brain to reduce pain perception.
This drug works by targeting the opioid receptors in the brain to reduce pain perception. Used for Management of moderate to severe pain.
At a glance
| Generic name | Standard pain management regimen |
|---|---|
| Also known as | Pharmacological pain relief |
| Sponsor | Cedars-Sinai Medical Center |
| Drug class | opioid |
| Target | opioid receptors |
| Modality | Small molecule |
| Therapeutic area | Pain management |
| Phase | Phase 3 |
Mechanism of action
The exact mechanism of action is not fully understood, but it is believed to involve the activation of opioid receptors, leading to a decrease in the transmission of pain signals to the brain. This results in a reduction in the perception of pain, providing relief to patients.
Approved indications
- Management of moderate to severe pain
Common side effects
- Nausea
- Dizziness
- Constipation
- Vomiting
- Headache
- Fatigue
- Drowsiness
- Itching
- Rash
- Sedation
Key clinical trials
- Examining Analgesic Synergy and Efficacy in Trauma Care (PHASE4)
- Acupuncture for Colorectal sUrgery Recovery Enhancement: A Randomized Controlled Trial Evaluating Gastrointestinal Functional Recovery After Minimally Invasive Resection (NA)
- Ultrasound-Guided Quadro-Iliac Plane Block for Pain Management After Total Hip Arthroplasty (NA)
- Continous Infusion of Nefopam for Patients Undergoing Pancreatoduodenectomy (PHASE4)
- Comparison of Intrathecal Morphine and Rectus Sheath Block for Postoperative Pain Management After Lower Abdominal Surgery With Midline Incision (NA)
- Effectiveness of Stanley Paris Manual Therapy vs. Conventional Physiotherapy in Reducing Pain and Improving Function in Grade II Knee Osteoarthritis (NA)
- Opioid Free and Opioid Based Anesthesia in Elective Lumbar Spine Surgery
- PENG Block & PENG PRF
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Standard pain management regimen CI brief — competitive landscape report
- Standard pain management regimen updates RSS · CI watch RSS
- Cedars-Sinai Medical Center portfolio CI